12/16/2024
3:16 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
1:58 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
11:10 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4/A | |
12/06/2024
11:11 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
12/06/2024
11:12 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4/A | |
12/06/2024
11:13 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4/A | |
12/04/2024
1:33 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/04/2024
1:35 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:37 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:49 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
GEYGAN JAMES (Reporting)
GEYGAN JEFFREY RICHART (Reporting)
Geygan Kathleen (Reporting)
GLOBAL VALUE INVESTMENT CORP. (Reporting)
Rice Shawn G (Reporting)
Wilke Stacy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/03/2024
4:15 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/02/2024
5:40 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 424B5 | |
12/02/2024
5:03 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:32 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
11/15/2024
3:30 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:36 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
1:26 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
11:15 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form EFFECT | |
08/27/2024
8:00 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/26/2024
4:18 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
08/23/2024
3:35 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
08/23/2024
3:36 PM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
08/21/2024
1:24 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
10:59 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:01 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:03 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:04 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
11:20 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q/A | |
08/19/2024
4:13 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
4:01 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
07/22/2024
3:52 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
07/17/2024
5:20 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:00 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
11:40 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:49 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
2:51 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
11:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:06 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:10 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Cackling Kamala hates this company (Ad) Do you want to see one of the most exciting election trades of all time?
A trade that could help America become 100% energy independent…
Reduce energy costs to virtually zero…
And hand investors what could be a stunning return in just a few years’ time?
It all has to do with a little known company that is helping to kick off the next great American energy revolution.  Before that happens, you need to see the details here. |
07/02/2024
9:13 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
7:53 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:54 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:55 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:56 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:45 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
06/18/2024
3:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
11:14 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEFA14A | |
06/07/2024
10:35 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEF 14A | |
05/30/2024
3:45 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/23/2024
4:19 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form PRE 14A | |
05/20/2024
4:28 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
05/16/2024
7:02 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
11:21 AM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
05/16/2024
11:22 AM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
05/15/2024
8:55 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:30 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:50 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
3:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:22 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
4:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form ARS | |
04/02/2024
3:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
5:01 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:16 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:17 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:26 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:40 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:41 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:23 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:24 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
03/06/2024
5:25 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:25 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:05 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:51 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
| Form SC 13G/A | |
02/12/2024
3:54 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEF 14A | |
02/08/2024
9:30 AM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
WELLINGTON TRUST Co N A (Filed by)
| Form SC 13G/A | |
02/01/2024
3:50 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form PRE 14A | |
01/19/2024
3:36 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
2:32 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:05 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
